Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Investigation of Susceptibility to Liver Toxicity in Patients With Multiple Sclerosis Treated With Fingolimod

NCT05516303 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT05516303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05516303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Investigation of Susceptibility to Liver Toxicity in Patients With Multiple Sclerosis Treated With Fingolimod
Lead sponsor
University Hospital, Caen
Phase
Observational
Overall status
Unknown status
Start date
June 7, 2022
Completion date
October 31, 2022
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis